← Leaderboards
Stephen B Kahl
University Of California San Francisco
$7,278,768
Attributed
$7,278,768
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,278,768 · 12
By mechanism
R44$3,969,403 · 2
R01$2,973,900 · 1
R43$288,301 · 1
P41$47,164 · 8
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Warner C Greene$31,742,202
- John P. Murnane$6,328,070
- Alan S Verkman$35,167,321
- Joseph M McCune$87,907,605
- John W Sedat$5,327,434
Others in their field
Top investigators on “Porphyrins”
- Jonathan F Lovell · State University Of New York At Buffalo$9,226,863
- Kit S Lam · University Of California At Davis$7,976,399
- Edward I Solomon · Stanford University$7,592,867
- Brian J Day · National Jewish Health$7,464,802
- X. Peter Zhang · Boston College$7,439,369
- Timothy A Derouen · University Of Washington$6,319,081
Research focus
PorphyrinsGrantDesignBoronRecombinantsIn VivoFundingBoron Neutron Capture TherapyTumorGliomaProtocols DocumentationDoseToxic EffectAnimalsRattusResearch PersonnelIn VitroMediatingChemistryLinkMalignant NeoplasmsPublishingProteinsCells
Grant awards (26)
Toxicology (IND-enabling) studies for a novel nerve imaging agent for prostate cancer$1,090,970
R44 · FY2025 · CA · contact PI
Toxicology (IND-enabling) studies for a novel nerve imaging agent for prostate cancer$905,526
R44 · FY2024 · CA · contact PI
Nonclinical development of Nervelight, an intra-operative peripheral nerve imaging agent$752,754
R44 · FY2018 · CA · contact PI
Nonclinical development of Nervelight, an intra-operative peripheral nerve imaging agent$1,220,153
R44 · FY2017 · CA · contact PI
In vivo feasibility of a peripheral nerve imaging agent$288,301
R43 · FY2013 · CA · contact PI
BORONATED TUMOR SEEKING PORPHYRINS SYNTHESIS & TESTING$50
P41 · FY2011 · RR · contact PI
Program for Development of BNCT Agents$297,714
R01 · FY2010 · CA · contact PI
BORONATED TUMOR SEEKING PORPHYRINS SYNTHESIS & TESTING$19,431
P41 · FY2010 · RR · contact PI
Program for Development of BNCT Agents$297,714
R01 · FY2009 · CA · contact PI
BORONATED TUMOR SEEKING PORPHYRINS SYNTHESIS & TESTING$1,330
P41 · FY2009 · RR · contact PI
Program for Development of BNCT Agents$297,392
R01 · FY2008 · CA · contact PI
BORONATED TUMOR SEEKING PORPHYRINS SYNTHESIS & TESTING$1,004
P41 · FY2008 · RR · contact PI
Program for Development of BNCT Agents$296,623
R01 · FY2007 · CA · contact PI
BORONATED TUMOR SEEKING PORPHYRINS SYNTHESIS & TESTING$4,480
P41 · FY2007 · RR · contact PI
Program for Development of BNCT Agents$297,216
R01 · FY2006 · CA · contact PI
BORONATED TUMOR SEEKING PORPHYRINS SYNTHESIS & TESTING$3,291
P41 · FY2006 · RR · contact PI
BORONATED TUMOR SEEKING PORPHYRINS SYNTHESIS &TESTING$2,676
P41 · FY2005 · RR
PROGRAM FOR DEVELOPMENT OF BNCT AGENTS$298,688
R01 · FY2004 · CA
BORONATED TUMOR SEEKING PORPHYRINS SYNTHESIS &TESTING$5,022
P41 · FY2004 · RR
PROGRAM FOR DEVELOPMENT OF BNCT AGENTS$298,688
R01 · FY2003 · CA
PROGRAM FOR DEVELOPMENT OF BNCT AGENTS$298,688
R01 · FY2002 · CA
BORONATED TUMOR SEEKING PORPHYRINS: SYNTHESIS &TESTING$0
P41 · FY2002 · RR
PROGRAM FOR DEVELOPMENT OF BNCT AGENTS$298,688
R01 · FY2001 · CA
BORONATED TUMOR SEEKING PORPHYRINS: SYNTHESIS &TESTING$0
P41 · FY2001 · RR
PROGRAM FOR DEVELOPMENT OF BNCT AGENTS$292,489
R01 · FY2000 · CA
BORONATED TUMOR SEEKING PORPHYRINS: SYNTHESIS &TESTING$9,880
P41 · FY2000 · RR